281 related articles for article (PubMed ID: 31921146)
1. Interplay Between Macrophages and Angiogenesis: A Double-Edged Sword in Liver Disease.
Ramirez-Pedraza M; Fernández M
Front Immunol; 2019; 10():2882. PubMed ID: 31921146
[TBL] [Abstract][Full Text] [Related]
2. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
3. Targeting hepatic macrophages to treat liver diseases.
Tacke F
J Hepatol; 2017 Jun; 66(6):1300-1312. PubMed ID: 28267621
[TBL] [Abstract][Full Text] [Related]
4. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.
Taura K; De Minicis S; Seki E; Hatano E; Iwaisako K; Osterreicher CH; Kodama Y; Miura K; Ikai I; Uemoto S; Brenner DA
Gastroenterology; 2008 Nov; 135(5):1729-38. PubMed ID: 18823985
[TBL] [Abstract][Full Text] [Related]
5. Macrophages in the Aging Liver and Age-Related Liver Disease.
Stahl EC; Haschak MJ; Popovic B; Brown BN
Front Immunol; 2018; 9():2795. PubMed ID: 30555477
[TBL] [Abstract][Full Text] [Related]
6. [Progress in researches on macrophages in liver fibrosis of schistosomiasis].
Xie YY; Xu YH; Chu DY; Shen JL
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2015 Dec; 27(6):669-73. PubMed ID: 27097498
[TBL] [Abstract][Full Text] [Related]
7. Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease.
Li X; Yao QY; Liu HC; Jin QW; Xu BL; Zhang SC; Tu CT
J Cell Mol Med; 2017 Oct; 21(10):2370-2385. PubMed ID: 28378526
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases.
van der Heide D; Weiskirchen R; Bansal R
Front Immunol; 2019; 10():2852. PubMed ID: 31849997
[TBL] [Abstract][Full Text] [Related]
9. Placental Growth Factor Contributes to Liver Inflammation, Angiogenesis, Fibrosis in Mice by Promoting Hepatic Macrophage Recruitment and Activation.
Li X; Jin Q; Yao Q; Zhou Y; Zou Y; Li Z; Zhang S; Tu C
Front Immunol; 2017; 8():801. PubMed ID: 28744285
[TBL] [Abstract][Full Text] [Related]
10. Macrophage in liver Fibrosis: Identities and mechanisms.
Wang Z; Du K; Jin N; Tang B; Zhang W
Int Immunopharmacol; 2023 Jul; 120():110357. PubMed ID: 37224653
[TBL] [Abstract][Full Text] [Related]
11. Liver inflammation and fibrosis.
Koyama Y; Brenner DA
J Clin Invest; 2017 Jan; 127(1):55-64. PubMed ID: 28045404
[TBL] [Abstract][Full Text] [Related]
12. The interplay between macrophages and angiogenesis in development, tissue injury and regeneration.
Nucera S; Biziato D; De Palma M
Int J Dev Biol; 2011; 55(4-5):495-503. PubMed ID: 21732273
[TBL] [Abstract][Full Text] [Related]
13. Immunity, tolerance and autoimmunity in the liver: A comprehensive review.
Doherty DG
J Autoimmun; 2016 Jan; 66():60-75. PubMed ID: 26358406
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of vascular endothelial growth factor signaling facilitates liver repair from acute ethanol-induced injury in zebrafish.
Zhang C; Ellis JL; Yin C
Dis Model Mech; 2016 Nov; 9(11):1383-1396. PubMed ID: 27562099
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Kupffer cells reduced CXC chemokine production and liver injury.
Mosher B; Dean R; Harkema J; Remick D; Palma J; Crockett E
J Surg Res; 2001 Aug; 99(2):201-10. PubMed ID: 11469888
[TBL] [Abstract][Full Text] [Related]
16. Cytokines and chronic liver disease.
Fainboim L; Cherñavsky A; Paladino N; Flores AC; Arruvito L
Cytokine Growth Factor Rev; 2007; 18(1-2):143-57. PubMed ID: 17324606
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in liver regeneration and fibrosis: "a double-edged sword".
Kaur S; Anita K
Hepatol Int; 2013 Oct; 7(4):959-68. PubMed ID: 26202026
[TBL] [Abstract][Full Text] [Related]
18. Pathological process of liver sinusoidal endothelial cells in liver diseases.
Ni Y; Li JM; Liu MK; Zhang TT; Wang DP; Zhou WH; Hu LZ; Lv WL
World J Gastroenterol; 2017 Nov; 23(43):7666-7677. PubMed ID: 29209108
[TBL] [Abstract][Full Text] [Related]
19. Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?
Seo W; Jeong WI
World J Gastroenterol; 2016 Jan; 22(4):1348-56. PubMed ID: 26819504
[TBL] [Abstract][Full Text] [Related]
20. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
